SCANDMEDICAL SOLDK-040 (Germany) Price Prediction
| K41 Stock | 0.61 0.14 18.67% |
Momentum 50
Impartial
Oversold | Overbought |
Using SCANDMEDICAL SOLDK-040 hype-based prediction, you can estimate the value of SCANDMEDICAL SOLDK 040 from the perspective of SCANDMEDICAL SOLDK-040 response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in SCANDMEDICAL SOLDK-040 to buy its stock at a price that has no basis in reality. In that case, they are not buying SCANDMEDICAL because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
SCANDMEDICAL SOLDK-040 after-hype prediction price | EUR 0.61 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
SCANDMEDICAL |
SCANDMEDICAL SOLDK-040 After-Hype Price Prediction Density Analysis
As far as predicting the price of SCANDMEDICAL SOLDK-040 at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in SCANDMEDICAL SOLDK-040 or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of SCANDMEDICAL SOLDK-040, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
SCANDMEDICAL SOLDK-040 Estimiated After-Hype Price Volatility
In the context of predicting SCANDMEDICAL SOLDK-040's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on SCANDMEDICAL SOLDK-040's historical news coverage. SCANDMEDICAL SOLDK-040's after-hype downside and upside margins for the prediction period are 0.03 and 3.95, respectively. We have considered SCANDMEDICAL SOLDK-040's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
SCANDMEDICAL SOLDK-040 is abnormally volatile at this time. Analysis and calculation of next after-hype price of SCANDMEDICAL SOLDK 040 is based on 3 months time horizon.
SCANDMEDICAL SOLDK-040 Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as SCANDMEDICAL SOLDK-040 is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading SCANDMEDICAL SOLDK-040 backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with SCANDMEDICAL SOLDK-040, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.19 | 3.34 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.61 | 0.61 | 0.00 |
|
SCANDMEDICAL SOLDK-040 Hype Timeline
SCANDMEDICAL SOLDK 040 is now traded for 0.61on Frankfurt Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. SCANDMEDICAL is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is now at -0.19%. %. The volatility of related hype on SCANDMEDICAL SOLDK-040 is about 0.0%, with the expected price after the next announcement by competition of 0.61. The company had not issued any dividends in recent years. Assuming the 90 days horizon the next estimated press release will be uncertain. Check out SCANDMEDICAL SOLDK-040 Basic Forecasting Models to cross-verify your projections.SCANDMEDICAL SOLDK-040 Related Hype Analysis
Having access to credible news sources related to SCANDMEDICAL SOLDK-040's direct competition is more important than ever and may enhance your ability to predict SCANDMEDICAL SOLDK-040's future price movements. Getting to know how SCANDMEDICAL SOLDK-040's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how SCANDMEDICAL SOLDK-040 may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SW6 | Stag Industrial | 0.00 | 0 per month | 0.00 | (0.01) | 1.41 | (2.03) | 5.12 | |
| 31WN | Western Copper and | 0.00 | 0 per month | 3.16 | 0.04 | 6.12 | (5.83) | 16.62 | |
| ZYR1 | CORNISH METALS INC | 0.00 | 0 per month | 3.82 | 0.01 | 7.43 | (6.99) | 27.35 | |
| GG7 | GRIFFIN MINING LTD | 0.00 | 0 per month | 2.00 | 0.17 | 5.23 | (4.44) | 13.77 | |
| AOX | alstria office REIT AG | 0.00 | 0 per month | 0.00 | (0.10) | 1.85 | (1.43) | 29.25 | |
| T7W | Treasury Wine Estates | 0.00 | 0 per month | 0.00 | (0.12) | 2.54 | (2.96) | 9.01 | |
| 719 | 24SEVENOFFICE GROUP AB | 0.00 | 0 per month | 4.64 | 0.03 | 2.91 | (2.70) | 34.93 | |
| 5PMA | GREENX METALS LTD | 0.00 | 0 per month | 2.95 | 0.12 | 6.52 | (5.88) | 20.17 |
SCANDMEDICAL SOLDK-040 Additional Predictive Modules
Most predictive techniques to examine SCANDMEDICAL price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for SCANDMEDICAL using various technical indicators. When you analyze SCANDMEDICAL charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About SCANDMEDICAL SOLDK-040 Predictive Indicators
The successful prediction of SCANDMEDICAL SOLDK-040 stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as SCANDMEDICAL SOLDK 040, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of SCANDMEDICAL SOLDK-040 based on analysis of SCANDMEDICAL SOLDK-040 hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to SCANDMEDICAL SOLDK-040's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to SCANDMEDICAL SOLDK-040's related companies.
Story Coverage note for SCANDMEDICAL SOLDK-040
The number of cover stories for SCANDMEDICAL SOLDK-040 depends on current market conditions and SCANDMEDICAL SOLDK-040's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that SCANDMEDICAL SOLDK-040 is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about SCANDMEDICAL SOLDK-040's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Complementary Tools for SCANDMEDICAL Stock analysis
When running SCANDMEDICAL SOLDK-040's price analysis, check to measure SCANDMEDICAL SOLDK-040's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SCANDMEDICAL SOLDK-040 is operating at the current time. Most of SCANDMEDICAL SOLDK-040's value examination focuses on studying past and present price action to predict the probability of SCANDMEDICAL SOLDK-040's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SCANDMEDICAL SOLDK-040's price. Additionally, you may evaluate how the addition of SCANDMEDICAL SOLDK-040 to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |